News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Precautionary recall of Amoxicillin Actavis Powder

Precautionary recall of Amoxicillin Actavis Powder for Oral Suspension (125 mg/5 mL and 250 mg/5 mL)

Auckland, 17 July 2014 - Actavis New Zealand Ltd confirms that as a precautionary measure and in close co-ordination with the New Zealand Medicines and Medical Devices Safety Authority, Medsafe, in New Zealand, the company has issued a consumer level recall of all batches of Amoxicillin Actavis Powder for Oral Suspension 125mg/5mL and 250mg/5mL. This recall is being madeto all pharmacies, pharmaceutical wholesalers and consumers.

The recall of Amoxicillin Actavis Powder for Oral Suspension is being taken as a precaution due to a potential for glass fragments to be present in the bottle. Amoxicillin Actavis Powder for OralSuspension is supplied in a glass bottle and there is a small possibility of glass fragments entering the powder.

The company is advising all healthcare professionals, distributors and consumers to return product to the supplier through the appropriate channels, as part of the recall.

Actavis is working closely with Medsafe to rigorously investigate the matter.

Actavis is committed to being a global leader in improving the health and quality of people’s lives worldwide. The company is committed to adherence to all applicable regulatory requirements andindustry standards, and ensures compliance by continuous assessment and monitoring of the oversight of the existing quality systems, and application of evolving industry guidelines and regulations.

About Actavis
Actavis New Zealand Ltd. is a subsidiary specialty pharmaceutical company Actavis plc (NYSE: ACT). Headquartered in Dublin, Ireland, Actavis plc is focused on developing, manufacturing andcommercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world.

Actavis markets a broad portfolio of branded and generic pharmaceuticals and develops innovative medicines for patients suffering from diseases principally in the central nervous system,gastroenterology, women's health, urology, cardiovascular, respiratory and anti-infective therapeutic categories. The Company is an industry leader in product research and development, with one ofthe broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submission of generic product applications. Actavis has commercial operations in more than 60countries and operates more than 30 manufacturing and distribution facilities around the world.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Album Review: Donnie Trumpet And The Social Experiments: Surf

Chance the Rapper is one of my favourite rappers of the last couple years. He bought a uniquely fucked up, acid sound with his debut Acid Rap which has demonstrably influenced others including ILoveMakonnen and A$AP Rocky. It’s remarkable that, at such a ... More>>

Photos: Inside The Christchurch Arts Centre Rebuild

Lady Pippa Blake visited Christchurch Arts Centre chief executive André Lovatt, a 2015 recipient of the Blake Leader Awards. The award celebrated Lovatt’s leadership in New Zealand and hisand dedication to the restoration of the Arts Centre. More>>

Running Them Up The Flagpole: Web Tool Lets Public Determine New Zealand Flag

A School of Design master’s student is challenging the flag selection process by devising a web tool that allows the public to feed their views back in a way, he says, the current government process does not. More>>

ALSO:

Survey: ‘The Arts Make My Life Better’: New Zealanders

New Zealanders are creative people who believe being involved in the arts makes their lives better and their communities stronger. Nine out of ten adult New Zealanders (88%) agree the arts are good for them and eight out of ten (82%) agree that the arts help to improve New Zealand society. More>>

ALSO:

Wellington.Scoop: Reprieve For Te Papa Press

Following its review of the role of Te Papa Press, Te Papa has committed to continue publishing books during the museum’s redevelopment, Chief Executive Rick Ellis announced yesterday. More>>

Law Society: Sir Peter Williams QC, 1934 - 2015

“Sir Peter was an exceptional advocate. He had the ability to put the defence case for his clients with powerful oratory. His passion shone through in everything he did and said.” Mr Moore says Sir Peter’s lifelong commitment to prison reform was instrumental in ensuring prison conditions and the rights of prisoners were brought to public attention. More>>

ALSO:

CTU: Peter Conway – Family Statement

Peter committed his whole working life to improving the lives of working people, both in unions and, more recently, as the Economist and Secretary of the Council of Trade Unions. He was previously Chair of Oxfam New Zealand and was on the Board of NZ Trade and Enterprise. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news